These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 162689)

  • 1. Heparin insensitivity responding to fresh frozen plasma.
    Reuter NF
    Minn Med; 1978 Feb; 61(2):79-81. PubMed ID: 162689
    [No Abstract]   [Full Text] [Related]  

  • 2. Should heparin be managed with a nomogram?
    Vine DL
    Kans Med; 1992 Dec; 93(12):359, 360. PubMed ID: 1287287
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative dosage and toxicity of heparin sodium in the treatment of patients with pulmonary embolism versus deep-vein thrombosis.
    Tenero DM; Bell HE; Deitz PA; Bertino JS
    Clin Pharm; 1989 Jan; 8(1):40-3. PubMed ID: 2912663
    [No Abstract]   [Full Text] [Related]  

  • 4. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis.
    Wheeler AP; Jaquiss RD; Newman JH
    Arch Intern Med; 1988 Jun; 148(6):1321-5. PubMed ID: 3377615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of deep venous thrombosis].
    Mesters RM
    Internist (Berl); 1999 Oct; 40(10):1098-9. PubMed ID: 10610366
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heparin-induced thrombocytopenia and thrombosis with spinal ischemia].
    Maurin N; Biniek R; Bohndorf K; Heintz B; Kierdorf H; Schulte-Bockholt A
    Internist (Berl); 1991 Jul; 32(7):431-4. PubMed ID: 1657813
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin induced thrombocytopenia: case reports and a prospective study.
    Romeril KR; Hickton CM; Hamer JW; Heaton DC
    N Z Med J; 1982 Apr; 95(706):267-9. PubMed ID: 6953369
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heparin-induced thrombosis-thrombocytopenia syndrome in Crohn disease. Further thromboses with oral anticoagulation after discontinuation of heparin].
    Eisenlohr H; Trenkwalder P; Lydtin H
    Internist (Berl); 1992 Jun; 33(6):432-4. PubMed ID: 1352765
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular reference to retroperitoneal bleeding.
    Holm HA; Abildgaard U; Kalvenes S
    Thromb Haemost; 1985 Apr; 53(2):278-81. PubMed ID: 4024037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fever and pleuritis in a postpartum patient.
    Jaff MR
    Cleve Clin J Med; 1995; 62(2):86-8. PubMed ID: 7736632
    [No Abstract]   [Full Text] [Related]  

  • 12. Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.
    Schutgens RE; Esseboom EU; Snijder RJ; Haas FJ; Verzijlbergen F; Nieuwenhuis HK; Lisman T; Biesma DH
    J Lab Clin Med; 2004 Aug; 144(2):100-7. PubMed ID: 15322504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculation of heparin dosage in a morbidly obese woman.
    Ellison MJ; Sawyer WT; Mills TC
    Clin Pharm; 1989 Jan; 8(1):65-8. PubMed ID: 2912669
    [No Abstract]   [Full Text] [Related]  

  • 14. The successful application of a heparin nomogram in a community hospital.
    Hollingsworth JA; Rowe BH; Brisebois FJ; Thompson PR; Fabris LM
    Arch Intern Med; 1995 Oct; 155(19):2095-100. PubMed ID: 7575069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy in patients with submassive pulmonary embolism.
    Berlin DA
    N Engl J Med; 2003 Jan; 348(4):357-9; author reply 357-9. PubMed ID: 12542062
    [No Abstract]   [Full Text] [Related]  

  • 16. [Plasma antithrombin III activity in patients with pulmonary thromboembolism].
    Vertun B; Filipecki S; Szczepański M; Wawrzyńska L; Rózycka J
    Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):726-9. PubMed ID: 1488357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of low-dose heparin prophylaxis in gynecologic oncology surgery.
    Clarke-Pearson DL; DeLong ER; Synan IS; Creasman WT
    Obstet Gynecol; 1984 Nov; 64(5):689-94. PubMed ID: 6493660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin therapy.
    Raich PC; Hahn MF; Korst DR
    Am Fam Physician; 1974 Sep; 10(3):163-8. PubMed ID: 4413661
    [No Abstract]   [Full Text] [Related]  

  • 19. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time].
    Lutze G; Presser HJ; Urbahn H
    Z Gesamte Inn Med; 1989 Apr; 44(8):235-40. PubMed ID: 2662657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring heparin therapy by thrombin time and activated partial thromboplastin time--a comparison].
    Lang M; Fey MF; Furlan M; Beck EA
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1681-4. PubMed ID: 3798064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.